Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614406 · ClinicalTrials.gov registry record · NA
The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00614406 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 11 participants.
The verdict
NCT00614406, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The investigators propose to test the hypothesis that the use of a prostaglandin inhibitor will result in premature luteolysis (ovulation failure) in women.
Interventions
- DRUG Placebo
- DRUG Celebrex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614406
The ClinicalTrials.gov registry entry for NCT00614406 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00614406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614406 about?
NCT00614406 is a clinical study titled "The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle". The investigators propose to test the hypothesis that the use of a prostaglandin inhibitor will result in premature luteolysis (ovulation failure) in women.
What is the current status of trial NCT00614406?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2008-01. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00614406?
The interventions under investigation include: Placebo (DRUG), Celebrex (DRUG).
Who is sponsoring clinical trial NCT00614406?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.